ArQule is a personalized medicine company working in the oncology space to develop treatments that target specific mutations. The Massachusetts-based company faces many challenges in this space, including one that is common to many cancer treatments.
Overcome The Challenges Of An Ultra-Rare Disease Trial
By Michael Tattory|
2018-11-20T13:15:01-04:00
November 20th, 2018|News|Comments Off on Overcome The Challenges Of An Ultra-Rare Disease Trial